Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-01 4:10 pm Sale | 2024-02-28 | 13D | Lantern Pharma Inc. LTRN | Bios Equity Partners LP | 1,263,802 11.800% | -202,889 (-13.83%) | Filing History |
| 2024-02-14 4:05 pm Sale | 2023-12-31 | 13G | Lantern Pharma Inc. LTRN | ProPhase Labs Inc. PRPH | 631,195 5.800% | -278,805 (-30.64%) | Filing History |
| 2023-12-01 06:02 am Sale | 2023-11-29 | 13D | Lantern Pharma Inc. LTRN | Bios Equity Partners LP | 1,466,691 13.600% | -508,150 (-25.73%) | Filing History |
| 2022-11-21 4:15 pm Purchase | 2022-11-08 | 13G | Lantern Pharma Inc. LTRN | ProPhase Labs Inc. PRPH | 910,000 8.400% | 910,000 (New Position) | Filing History |
| 2022-03-22 4:15 pm Purchase | 2022-03-17 | 13D | Lantern Pharma Inc. LTRN | Bios Equity Partners LP | 1,974,841 18.100% | 5,855 (+0.30%) | Filing History |
| 2022-01-11 10:31 am Sale | 2021-12-31 | 13G | Lantern Pharma Inc. LTRN | Empery Asset Management LP | 0 0.000% | -700,000 (Position Closed) | Filing History |
| 2021-02-16 4:02 pm Purchase | 2020-12-31 | 13G | Lantern Pharma Inc. LTRN | Green Park & Golf Ventures LLC | 672,758 6.400% | 672,758 (New Position) | Filing History |
| 2021-02-16 1:15 pm Purchase | 2020-12-31 | 13G | Lantern Pharma Inc. LTRN | Asaithambi Arunkumar | 470,460 4.500% | 470,460 (New Position) | Filing History |
| 2021-01-25 09:41 am Purchase | 2021-01-14 | 13G | Lantern Pharma Inc. LTRN | Empery Asset Management LP | 700,000 6.660% | 700,000 (New Position) | Filing History |
| 2020-06-23 3:17 pm Purchase | 2020-06-15 | 13D | Lantern Pharma Inc. LTRN | Bios Equity Partners LP | 1,968,986 30.600% | 1,968,986 (New Position) | Filing History |
| 2020-06-22 5:46 pm Purchase | 2020-06-15 | 13D | Lantern Pharma Inc. LTRN | BIOLOGICAL MIMETICS INC | 1,058,231 17.000% | 1,058,231 (New Position) | Filing History |
| 2020-06-19 4:05 pm Purchase | 2020-06-15 | 13D | Lantern Pharma Inc. LTRN | SHARMA PANNA | 495,486 7.400% | 495,486 (New Position) | Filing History |